Mirum Pharmaceuticals reports inducement grants under Nasdaq Listing Rule 5635(c)(4)
Mirum Pharmaceuticals Inc MIRM
$95.49
▼ -6.55%
($-6.70)
Open
$102.19
Prev Close
$102.19
Day Range
$94.31 – $102.56
52W Range
$42.89 – $114.99
Market Cap
$5.82B
Beta
0.51
EPS (TTM)
$-13.60
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2019-07-18 |
| Shares Out. | 60,340,000 |
| Website | mirumpharma.com/ ↗ |
| Phone | 13023368212 |
Mirum Pharmaceuticals Inc is a publicly traded company under the ticker symbol MIRM on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
17 analysts (2026-05-01)
📰 Latest News for MIRM
Mirum Pharmaceuticals Prices $600.0 Million Convertible Senior Notes Offering; Refinances a Portion of 2029 Convertible Notes
Mirum Pharmaceuticals Announces Proposed $600M Offering Of Notes Due 2032
Mirum Pharmaceuticals Announces Proposed Convertible Senior Notes Offering
Mirum Pharmaceuticals: A Rare Disease Platform Becoming Bigger Than Its First Franchise
Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences
TD Cowen Maintains Buy on Mirum Pharmaceuticals, Raises Price Target to $145
RBC Capital Maintains Outperform on Mirum Pharmaceuticals, Raises Price Target to $142